Literature DB >> 16300649

Cancer stem cells: lessons from leukaemia.

D Bonnet1.   

Abstract

Increasing evidence suggests that leukaemias are sustained by leukaemic stem cells. Leukaemia can indeed be viewed as aberrant haematopoietic processes initiated by rare leukaemic stem cells that have maintained or re-acquired the capacity for indefinite proliferation through accumulated mutations and/or epigenetic changes. Yet, despite their critical importance, much remains to be learned about the developmental origin of leukaemic stem cells and the molecular pathways underlying the transformation of normal cells into leukaemic stem cells. This report will review our current knowledge on leukaemic stem cells development and finally demonstrate how these discoveries provide a paradigm for identification of cancer stem cells from solid tumours.

Entities:  

Mesh:

Year:  2005        PMID: 16300649      PMCID: PMC6495794          DOI: 10.1111/j.1365-2184.2005.00353.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  22 in total

1.  The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.

Authors:  C T Jordan; D Upchurch; S J Szilvassy; M L Guzman; D S Howard; A L Pettigrew; T Meyerrose; R Rossi; B Grimes; D A Rizzieri; S M Luger; G L Phillips
Journal:  Leukemia       Date:  2000-10       Impact factor: 11.528

2.  Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.

Authors:  Antonio Cozzio; Emmanuelle Passegué; Paul M Ayton; Holger Karsunky; Michael L Cleary; Irving L Weissman
Journal:  Genes Dev       Date:  2003-12-15       Impact factor: 11.361

3.  MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice.

Authors:  Chi Wai So; Holger Karsunky; Emmanuelle Passegué; Antonio Cozzio; Irving L Weissman; Michael L Cleary
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

Review 4.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

5.  Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117).

Authors:  A Blair; H J Sutherland
Journal:  Exp Hematol       Date:  2000-06       Impact factor: 3.084

6.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

7.  Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-.

Authors:  A Blair; D E Hogge; H J Sutherland
Journal:  Blood       Date:  1998-12-01       Impact factor: 22.113

Review 8.  Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

Authors:  Emmanuelle Passegué; Catriona H M Jamieson; Laurie E Ailles; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

9.  Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.

Authors:  Kristin J Hope; Liqing Jin; John E Dick
Journal:  Nat Immunol       Date:  2004-05-30       Impact factor: 25.606

10.  Acute nonlymphocytic leukemia: heterogeneity of stem cell origin.

Authors:  P J Fialkow; J W Singer; J W Adamson; K Vaidya; L W Dow; J Ochs; J W Moohr
Journal:  Blood       Date:  1981-06       Impact factor: 22.113

View more
  3 in total

Review 1.  Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies.

Authors:  Luiza Handschuh
Journal:  J Oncol       Date:  2019-07-30       Impact factor: 4.375

2.  Angiogenesis-independent tumor growth mediated by stem-like cancer cells.

Authors:  Per Ø Sakariassen; Lars Prestegarden; Jian Wang; Kai-Ove Skaftnesmo; Rupavathana Mahesparan; Carla Molthoff; Peter Sminia; Eirik Sundlisaeter; Anjan Misra; Berit Bølge Tysnes; Martha Chekenya; Hans Peters; Gabriel Lende; Karl Henning Kalland; Anne M Øyan; Kjell Petersen; Inge Jonassen; Albert van der Kogel; Burt G Feuerstein; A Jorge A Terzis; Rolf Bjerkvig; Per Øyvind Enger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-20       Impact factor: 11.205

Review 3.  Role and clinical significance of TGF‑β1 and TGF‑βR1 in malignant tumors (Review).

Authors:  Junmin Wang; Hongjiao Xiang; Yifei Lu; Tao Wu
Journal:  Int J Mol Med       Date:  2021-02-19       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.